Background-Several high-risk morphological features (HRM) of plaques, especially in combination, are associated with an increased risk of a clinical event. Although plaque inflammation is also associated with atherothrombosis, the relationship between inflammation and number of HRM is not well understood.
S troke remains a leading cause of death in the developed and developing countries alike. 1, 2 Current diagnostic and therapeutic guidelines place substantial emphasis on luminal stenosis or its ischemic signature as an index of the severity of atherosclerosis. However, these lumino-centric indices fail to account for the morphological and molecular features of plaques that might provide useful information about risk of an atherothrombotic event.
Clinical Perspective on p 77
Inflammation is a key feature of plaques that are strongly related to atherothrombosis and ischemic cerebrovascular events. [3] [4] [5] Several high-risk morphological features (HRM) identified by noninvasive imaging modalities such as CT 6 -8 have been linked to an increased risk of ischemic cerebrovascular events, including the presence of expansive remodeling, lipid-rich necrotic core, and ulceration or plaque surface irregularity. 8 -11 In the coronary circulation, a 2-year follow-up study of more than 1000 patients demonstrated that a substantial increased risk for an acute coronary event occurs when HRM occur in combination, specifically with a frequency of 0.5%, 3.4%, and 22.2%, in patients who had 0, 1, and 2 HRM, respectively (PϽ0.001). 12 On the other hand, studies have shown that an increased carotid 18 flurodeoxyglucose (FDG) uptake on positron emission tomography (PET) imaging is associated with recent ischemic cerebrovascular events in patients. 13, 14 FDG-PET has been shown to measure plaque inflammation. [15] [16] [17] [18] [19] As such, imaging inflammation relative to the number of high-risk features may aid in the risk stratification of patients with low-to moderate-grade carotid disease in which therapeutic management is often uncertain. However, although data are available to describe the association between inflammation and single HRM, there are no data that describe the distribution of inflammation within plaques relative to the number of HRM they contain. Thus far, a handful of studies have been published evaluating the localization of FDG uptake relative to structural features. 19, 20 Moreover, no prior imaging study, and surprisingly, no prior histological series, has to our knowledge evaluated the relative distribution of inflammation across plaques relative to the distribution of HRM. Accordingly, in the current study, we sought to determine the distribution of inflammation relative to the distribution of HRM within carotid plaques. We used multidetector CT angiography (CTA) to identify HRM of plaques (remodeling, lipid pooling, and luminal irregularities) that have previously been associated with an increased risk of a clinical event. 8 -11 Further, we used both FDG-PET imaging and histological evaluation (in a subset of patients who underwent carotid endarterectomy [CEA]) to evaluate the distribution of inflammation versus plaque morphology.
Methods

Patients
Thirty-six patients underwent separate vascular PET and CTA imaging for research studies designed to evaluate carotid plaque inflammation at the Massachusetts General Hospital through 2009. The images of 2 patients were deemed to be of insufficient quality for analysis and were not measured, yielding a final dataset derived from 34 subjects. In these research studies, patients with acute or chronic inflammatory conditions were excluded at the time of screening period before imaging, based on past and current medical history, physical examination, and laboratory profile (eg, CBC, urinalysis, HBSAg, HIVAb, etc). A subset of 10 patients with severe carotid artery stenosis, defined as 70 -99% stenosis of the internal carotid artery as detected by carotid Doppler ultrasound, magnetic resonance angiography, or CT angiography were enrolled 1 month before undergoing carotid endarterectomy. These patients comprised a subset of a previously reported study evaluating the relationship between FDG uptake and plaque inflammation. 16 The subsequent 24 patients were enrolled if they have 1 of the following: (1) documented atherosclerosis in any vascular bed: carotid, coronary, or peripheral; (2) type 2 diabetes; or (3) obesity (body mass index of Ն30, Յ40 kg/m 2 ) ( Figure 1 ). The study protocol was approved by the local Human Research Committee; all patients provided written informed consent.
PET and CT Imaging
FDG was administered intravenously (10 -25 mCi) after an overnight fast, and imaging was performed 1.5-3 hours later, using a Siemens ECAT HRϩ PET system (Siemens, Knoxville, TN), which provides 4.2-mm intrinsic resolution. Patients were imaged in supine position, and images were in 3D mode obtained over 20 minutes. Reconstruction of attenuation-corrected images was performed using a filtered back-projection algorithm, generating an effective resolution of 5 mm. All patients had a blood sugar concentration of Ͻ200 mg/dL at the time of imaging.
A contrast-enhanced CT was performed using a Siemens 64 slice CT scanner (Siemens, Knoxville, TN) on the same day as the PET imaging, after contrast administration of iopamidol (Isovue 300; Bracco Diagnostics, Rome, Italy), 100 -140 mL at 3 mL/s. CT parameters included tube voltage of 120 kVp, tube current of 220 -250 mA, rotation time of 0.8 -1.0 seconds, section thickness of 2.5 mm reconstructed at 1.25-mm intervals, table speed of 3.75 mm/rotation, and pitch of 0.75:1.
Measurement of FDG Uptake With PET
Carotid FDG uptake was measured at 5-mm intervals along the long axis of the carotid artery (between 2 cm below and 3 cm above the bifurcation). At each axial cross section, a single region of interest (ROI) approximately 8 mm in diameter was drawn around the wall of the internal carotid artery, and the maximum standardized uptake value (SUVmax) was measured. SUV is the decay-corrected tissue concentration of FDG (kBq/mL) divided by the injected dose per body weight (kBq/g). Background FDG uptake was measured within a large vein (such as the subclavian or internal jugular vein). Target-to-background ratio (TBR) was calculated by dividing the carotid plaque SUVmax by the venous blood SUV, and a TBR value was then recorded for each axial section, referenced to distance from the carotid bifurcation. Coregistration of the PET and CT datasets was performed manually, using anatomic landmarks (such as brain, spinal cord, spine, and jaw) by an investigator blinded to the histological analysis, using a workstation that enables multimodal image fusion (Leonardo TrueD, Siemens, Knoxville, TN).
Characterization of Plaque Morphology With CT
Plaques were characterized by an investigator blinded to the clinical, PET, and histological data. CT measurements were made at 5-mm axial intervals within boundaries defined by (1) the surgical resection in the case of the CEA patients and (2) including the boundaries of the PET measurements. The CT observations were recorded relative to the distance from the carotid bifurcation to allow coregistration of data across PET, CT, and histological datasets. HRM were identified using the following criteria:
Low-attenuation plaque was defined as mean Hounsfield units (HU Ͻ30) within the plaque. A 5-mm ROI was drawn within the center of the low-attenuation plaque, after which the mean HU value was reported. This HU value of Ͻ30 has been shown to correlate with the presence of lipid-rich plaque and is associated with an increased incidence of clinical events. 12, 21 Positive remodeling was defined as a remodeling ratio of Ͼ1.05, which is the ratio between the external elastic membrane area at the lesion and the proximal reference site. 22 Luminal irregularity was defined as a clear out-pouching of contrast into the wall. The presence of luminal irregularities is associated with the presence of plaque ulcerations and is associated with increased risk for stroke. 9, 10 
Calcified Plaques
The presence of dense calcification was (qualitatively) assessed. Calcification was recognized as plaque with the density of Ͼ220 HU and was classified as large, dense calcification when Ͼ3 mm in size. 12 Discrete calcified nodules clearly surrounded by noncalcified plaques less than 3 mm in diameter ("spotty") were excluded.
Histology
Histological assessment of macrophage staining was performed using the method detailed by Jander et al. 23 In brief, formalin-fixed and decalcified specimens were embedded in paraffin, and 5-m sections (average of 4Ϯ2, standard deviation per plaque) were mounted on gelatin-coated slides for immunohistochemistry and subsequently were stained with a macrophage specific anti-CD68 monoclonal antibody (mAb KP-1; Dako, Glostrup, Denmark). Computer-assisted planimetry was used to quantify areas of macrophage staining, using previously reported methods. 16, 23 Color-encoded digitized images (using Sony CCD camera, Hamamatsu DVS video image processing unit, and National Institutes of Health image analyzing software on Apple Macintosh personal computer) of the carotid sections were obtained. Subsequently, areas of macrophage infiltration were outlined manually by comparing the computerized image with the microscopic image at 4ϫ and 20ϫ magnification. Macrophage staining at each carotid slice was reported as absolute area staining (mm 2 ) and percentage of plaque staining (% CD68) for macrophages. When plaque occupied greater than 180 degrees of the vessel wall, the most inflamed half (% CD68) of the vessel wall was reported. Histopathologic data were coregistered to the imaging data using distance from the carotid bifurcation, as previously reported. 16 Carotid bifurcation was defined as the apex of the luminal flow divider (dividing internal and external carotid artery) as identified on CT.
Coregistration and Comparison of Histological, CT, and PET Data
The axial PET and CT images were independently registered to histology sections on the basis of the distance from the common carotid bifurcation. The carotid bifurcation was defined as the apex of the luminal flow divider (which divides internal and external carotid artery) as identified on the PET and CT images, as well as in the pathological specimens. Data on the PET and CT data sets were recorded along axial images at 5-mm intervals and referenced according to inferosuperior distance from the flow divider (eg, 0, ϩ5 mm, ϩ10 mm, etc). Similarly, histological data were similarly referenced to the flow divider. Contraction (caused by axial elastic recoil) of the endarterectomy specimen during histological processing (between its relatively stretched state in vivo to a more contracted state ex vivo) was anticipated. A 25% contraction in the length of the specimens along the inferior-superior dimension was assumed, based on earlier experience of the laboratory. 16 
Statistical Methods
Descriptive data are presented as meanϮstandard error of the mean (SEM) for continuous parametric variables, median [interquartile range (IQR)] for continuous nonparametric data, and frequency with proportions for nominal variables as appropriate. We used the Mann-Whitney U test to compare inflammation (measured as CD68 staining or TBR) in segments: (1) with versus without plague, (2) with versus without dense calcium, and (3) with versus without specific morphological features (separately, for low attenuation, luminal irregularity, and remodeling). We used a linear mixed-effects model with random effects term to compare the TBR across vascular segments (plaques with HRM versus plaque-free and plaques without HRM) and to assess linear trend across the number of HRM separately for TBR and CD68. Additionally, Pearson and Spearman correlation (for normally and nonnormally distributed data, respectively) was used to determine correlation between CD68 versus TBR (CEA patients), on both for per-segment basis and per-patient basis. Further, the Generalized Estimating Equations model (logistic regression of correlated outcome data using the GENMOD procedure) was used to determine association between TBR and HRM (0 versus Ն1 HRM), accounting for within-subject correlations among vessels. Statistical significance was determined if the 2-tailed probability value was Ͻ0.05. All analyses were performed using SAS 9.2.
Results
Subject Characteristics
In total, 34 subjects were included in the study. The characteristics of the subjects are listed in Table 1 . Values are presented as meanϮSEM or n (%). CEA indicates carotid endarterectomy. *Transient neurologic symptoms in the distribution of the ipsilateral carotid artery with stenosis. Of these patients, 2 of 5 were symptomatic within 24 months before imaging, whereas 3 of 5 had symptoms within 6 months of imaging.
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CT Analysis of Plaque Morphology
Plaques were seen in 26 (76%) patients, whereas 7 (24%) patients had no evidence of plaques by CT within the examined portion of the carotid circulation. Structural analysis, with CT, was performed in 100 vascular segments (as seen on axial images), with an average of 3Ϯ2 (SD) per patient. The distribution of plaque morphological features is noted in Table 2 . Figure 4 ). Moreover, FDG uptake was found significantly higher in plaques with HRM compared with segments that contained no visible plaque (Pϭ0.0001) and compared with plaques without HRM (Pϭ0.0003). Uptake of FDG was also evaluated according to the presence or absence of specific HRM. FDG uptake was higher in plaques with (versus without): remodeling (median [IQR]: (3. 
FDG Uptake Localizes to Plaques With HRM
Analysis of Morphology and Inflammation in the Subset With Histological Specimens and PET
In a manner similar to that observed with FDG uptake, plaque inflammation, assessed with % CD68 staining, was greater in plaques with (versus without) any HRM Figure 5A ). Similar results were obtained with measurement of absolute area of macrophage staining (Table 3 ). Furthermore, the relationship between FDG uptake and plaque morphology was examined in that same subset of segments and was found to be similar to that observed between CD68 staining and plaque morphology ( Figure 5B and Table 3 ). Moreover, a linear trend (PϽ0.001) was observed between inflammation (by either % CD68 or FDG uptake) and the number of HRM ( Figure 6A and 6B and 
Discussion
In this proof-of-principle study, we compared carotid plaque morphology (by CT) with plaque inflammation (measured by PET and confirmed by histology) and observed that plaque morphology and inflammation are closely related. Not surprisingly, we observed that inflammation (FDG uptake) is higher in vascular segments that contain any plaque versus no plaque. Additionally, we observed that inflammation (measured by PET and histology) is higher in plaques with versus without HRM. Moreover, we observed that the inflammatory content of plaques increased with the number of HRM. These observations demonstrate that inflammation is a common denominator associated with HRM and highlight a close relationship between inflammation and increasing degrees of morphological pathology.
HRM Associated With Inflammation
It has been previously well demonstrated that inflammation is an important feature of plaques that contain single HRM features, such as positive remodeling, low attenuation, or luminal irregularities. Positive remodeling occurs through a mechanism that involves the release of matrix metalloproteinases by macrophages. 24 -28 Lipid-rich necrotic core, (the histopathologic correlate of low attenuation plaques) 29 is closely linked to inflammation and indeed is thought to form, in part, through apoptosis of macrophages. 30, 31 Luminal irregularities and ulcerations have been shown to be associated with plaque rupture 32 that is associated with activated macrophages. 4, 5 What has not been previously studied is the interrelationship between inflammation and multiple HRM features.
FDG-PET Imaging of Atherosclerosis
FDG-PET is a functional imaging technique with important clinical applications in cardiology, oncology, and neurology. Additionally, it has been shown to provide a measurement of atherosclerotic plaque inflammation in animal models and humans. [15] [16] [17] [18] [19] The vascular PET signal correlates well with macrophage content of plaques (but not plaque volume or smooth muscle cell content), is reproducible, and is modifiable by interventions that have an anti-inflammatory effect 33, 34 and identifies patients at high risk for an atherothrombotic event. 15, 16, 35, 36 This imaging technique is now being used in several multicenter trials examining the effect of therapies on atherosclerotic plaque inflammation. Despite its relative widespread use, relatively little is known regarding the distribution of Figure 2 . A, CT image of a plaque with luminal irregularity, low attenuation (LAP), and positive remodeling (PR). B, High FDG uptake within the same plaque, predominantly within the positively remodeled, lowattenuation region. C and D, Low-powered Trichrome-and CD68-stained specimens corresponding to the same location. Note the presence of 3 necrotic cores (NC), the second of which is ruptured and is consistent with the report of atheromatous material released after removal of the specimen. The most substantial CD68 staining is seen in NC1. E, High-powered CD68 micrograph of NC 1. Dispersed within the NC, and especially surrounding the NC, are discrete, darkly stained cells indicative of substantial macrophage infiltration. 
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FDG uptake relative to morphological features associated with plaques. Thus far, relatively few data have been published evaluating the localization of FDG relative to plaque structural features. One prospective study demonstrated that increased FDG uptake was associated with lipid-rich plaques assessed by MRI. 20 Moreover, in another prospective study, FDG uptake was shown to correlate with echolucency on ultrasound. 19 To our knowledge, no prior study has evaluated the relative distribution of inflammation across plaques relative to the distribution of HRM. The observation of a relationship between inflammation and HRM enhances our understanding of the link between HRM and clinical events, by pointing to plaque inflammation as a feature that increases within plaques relative to the number of HRM. The results of the study provide evidence that multimodality imaging with PET and CT provides complementary information about HRM and inflammation. Given the importance of both morphology and inflammation to subsequent atherothrombosis, it is possible that the combination of structure and inflammation imaging data may produce information that can improve clinical decision-making, a hypothesis that needs prospective evaluation.
Furthermore, we confirmed prior observations that FDG uptake is reduced in vascular segments containing densely calcified plaques 37 and extend that concept further by showing that macrophage staining is reduced in those same segments. However, it should be noted that we compared only dense versus no calcification, hence we did not evaluate the different patterns of moderate calcium deposition (eg, spotty calcification), which, in the coronaries, was observed to be closely linked with atherothrombotic risk. 21 
Limitations
Although the results of the present study are limited by the modest sample size, its strength lies in the simultaneous assessment of PET activity, plaque characteristics by CT, and histological validation. In this proof-of-principle study, we are able to demonstrate a relationship between plaque inflammation and increasing number of HRM that are believed to be associated with clinical events, 12 a finding that has potential clinical implication in terms of risk stratification of patients. However, the results must be validated in a larger study. Further, variability in the relationship between inflammation (FDG or CD68 data) and the number of HRM was observed ( Table 4 ). This may be the result of any of several factors, including the potential imperfect coregistration of imaging and histological datasets or because we only stained for macrophages (and did not include staining for other potential inflammatory cells). Although a good correlation was seen between FDG uptake, CD68, and number of HRM, several mismatches were observed (see Table 4 ). It is possible that some of this is caused by nonspecific perivascular FDG uptake, leading to misidentification of extravascular activity as vascular activity. It is also possible that some of the inflammatory signal was derived from the vascular adventitia, a location known to harbor substantial inflammation in atherosclerotic disease, yet that is not removed during endarterectomy, and hence was not included in this analysis. Additionally, the variability in the relationship between inflammation and number of HRM may reflect real differences in inflammation across plaques with a given number of HRM. This indeed may be expected, especially in patients recently started on therapies that have anti-inflammatory properties (such as statins), in which modulation of plaque inflammation may occur before the modulation of morphology. This raises the possibility that inflammatory and morphological measures of plaques may provide independent assessments of risk, a hypothesis that should be evaluated prospectively.
Additionally, the modest resolution of PET limits the ability to distinguish small clusters of inflammatory cells within 5 mm of each other. Accordingly, we did not consider differentiating closely spaced foci of activity. Instead, we reported a single value for both FDG uptake and CD68 staining per axial slice.
Further, partial volume error is expected when the target tissue diameter is near or below the resolution of the scanner. Although partial volume correction (PVC) may have given us a more precise measurement of FDG uptake, it was not used in the current study. Nonetheless, despite the limitations of the PET CT system and the lack of PVC, we observed a significant correlation between PET and histology. Thus, a stronger correlation may be observed if higher resolution systems were available and if PVC had been used.
Future Directions
Anticipated technological advancements, such as the development of PET-MRI, the ability to measure both PET activity, and plaque morphology on automatically coregistered images requiring little user input, probably will make measurement of plaque inflammation and morphology more widely accessible. Additionally, the development of novel tracers with greater sensitivity and specificity for inflammation will improve the accuracy of PET measures of plaque inflammation. Moreover, future efforts should evaluate the value of assessing local plaque inflammation for the prediction of atherothrombotic events in the carotid circulation. Ideally, such a study should compare the riskpredictive value of inflammatory imaging with that of structural imaging (for HRM determination), as well as assess the combination of the two datasets. It is also important to evaluate whether assessment of plaques for inflammation and HRM may help in the treatment of patients, especially in patients with asymptomatic moderate carotid stenosis, in which there is often difficulty in determining whether surgical or medical therapy is better.
Although prior prospective studies demonstrated that increased HRM are associated with increased risk, we observed that increased HRM is associated with increased inflammation. By combining these two observations, it follows that reducing inflammation in plaques with multiple HRM on imaging might result in reduction in atherothrombotic risk. Although the antiinflammatory effects of statins have been well-appreciated, 38 it is possible that novel anti-inflammatory therapeutics may provide additional benefits by reducing inflammation beyond what is produced by statins. Noninvasive imaging studies, perhaps 
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combining data regarding inflammatory content (by FDG-PET) with information regarding HRM (by CT or MRI), might inform of the potential salutary effects of anti-inflammatory interventions and provide confidence to proceed to clinical end point trials using the most promising treatments. Indeed, the ability to detect these high-risk plaques noninvasively is likely to serve as a powerful stimulus for intensification of efforts to develop such therapies. 39
Conclusions
This study demonstrates that inflammation, as assessed by both FDG uptake and histology, is increased in plaques containing 1 or more HRM. Further, the degree of inflammation increases with increasing number of HRM. Accordingly, the data support the concept that inflammation may act as a common mechanism to translate risk associated with HRM. Additional studies are warranted to evaluate the potential utility of combining inflammation imaging with structural imaging for the assessment of atherothrombotic risk. 
Sources of Funding
Disclosures
None. CT indicates computed tomography; PET, positron emission tomography; HRM, high-risk morphological features; TBR, target-to-background ratio; LAP, lowattenuation plaque; LI, luminal irregularity; and PR, positive remodeling.
25
